To get it approved, you would need to: Buy the patent (its for sale) Figure out a specific disease indication to apply for BPC-157 approval Hire a research team to run phase 1, 2, 3 trials The financial incentives make it so that BPC-157 will likely never go through the full FDA approval process, which is a shame given how promising this compound is
Similarly, cyclosporine and methotrexate are effective in reducing inflammation but are associated with significant risks, including nephrotoxicity, hypertension, and hepatotoxicity, limiting their long-term use [94]
It mimics the physiological actions of endogenous amylin effectively
It may also encourage collagen synthesis , which is vital for the integrity of muscles, tendons, and ligaments
Ice crystal formation during freezing physically shears peptide chains